Paddock et al v. Novartis Pharmaceuticals Corporation
Keri Sue Paddock, Laurie Boyle, Holly McCullogh, Michelle Del Valle, Tove Ghent, Cheyenne Moses, Julia Roer, Sandra Blanchette, Taryn Anthony and Christina Polanowski |
Novartis Pharmaceuticals Corporation |
1:2025cv00407 |
April 1, 2025 |
U.S. District Court for the District of Delaware |
Personal Inj. Prod. Liability |
28 U.S.C. ยง 1332 Diversity-Notice of Removal |
Both |
Docket Report
This docket was last retrieved on April 2, 2025. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 4 ANSWER to Complaint with Jury Demand by Novartis Pharmaceuticals Corporation.(Donelson, Matthew) |
Filing 3 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG, Corporate Parent Novartis Finance Corp for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (Donelson, Matthew) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cdd) |
Filing 1 NOTICE OF REMOVAL and copies of documents from Superior Court of the State of Delaware, Case Number K25C-03-046-NEP (Filing fee $405, receipt number ADEDC-4651548)- filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Civil Cover Sheet)(cdd) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.